This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1983-2000.
Location History:
- Gales Ferry, CT (US) (1983)
- Groton, CT (US) (2000)
Company Filing History:
Years Active: 1983-2000
Title: The Innovations of Bijan Rasadi
Introduction
Bijan Rasadi is a notable inventor based in Groton, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that address serious mental health conditions. With a total of 2 patents, Rasadi's work is recognized for its potential impact on treatment options for psychoses.
Latest Patents
Rasadi's latest patents include innovative formulations that enhance the efficacy of existing medications. One of his patents focuses on Ziprasidone formulations, which comprise crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles. These formulations have a mean particle size of less than 85 µm and are designed to be substantially bioequivalent, making them suitable for treating psychoses such as schizophrenia. Another significant patent involves aqueous micellar solutions of levonantradol and N-methyllevonantradol. These stable solutions are particularly useful for intramuscular administration and include lyophile formulations that are suitable for reconstitution.
Career Highlights
Bijan Rasadi is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with some of the brightest minds in the industry, contributing to advancements in drug formulations and therapeutic applications.
Collaborations
Some of Rasadi's notable coworkers include Daniel R Arenson and Frank R Busch. Their collaborative efforts have further enhanced the research and development initiatives within their projects.
Conclusion
Bijan Rasadi's contributions to pharmaceutical innovations demonstrate his commitment to improving treatment options for mental health conditions. His patents reflect a deep understanding of drug formulation and its implications for patient care.